Description
Market Analysis
Blood Collection for testing assumes a fundamental role in an effective medical treatment at the hospitals, healthcare and diagnostic centers all over the world. Blood test accumulation method incorporates a chain of sequence, and each sequence of this grouping is very imperative to keep up high-quality clinical outcomes. Global capillary blood collection devices market is anticipated to grow at a CAGR of 10.0% during the forecast period 2017–2023.
It has been noticed that the medical device regulation is the key factor driving the growth of the capillary blood collection devices market. Control of the usage of a medical device must be upgraded and improvised to protect the well-being of the patient. It must be ensured that high-quality products and effective technologies reach the patients. Developing interest for analysis of chronic diseases, the rising prevalence of diabetes, and expanding geriatric populace are additionally energizing the market development. However, the higher risk related to the capillary blood assortment technologies leading to blood contaminations may restrict the growth of the capillary blood collection devices market.
Market Segmentation
The global capillary blood collection devices market is divided on the basis of its type of devices, material, and end-user industry. On the basis of its type of devices, the global capillary blood collection devices market is bifurcated into lancets, blood collecting tubes and collector, and warming devices. Based on its material, the global market is classified into glass, plastic, stainless steel, and others. Based on its end -user, the market is sectioned into clinics, hospitals, home diagnostics, diagnostic centers and pathology laboratories, and others.
Regional Analysis
Geographically, the global capillary blood collection devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
Some of major players in the capillary blood collection devices market include companies like F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Novo Nordisk A S, Medtronic PLC, B. Braun Melsungen AG, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Ypsomed Holding AG, Terumo Corporation, HTL-STREFA S.A., Sarstedt AG & Co, Greiner Bio-One, Owen Mumford Ltd., Improve Medical, Weigao Group, Chengdu Rich Science Industry Co., Ltd., Nipro, Weihai Hongyu Medical Devices, Medigard, and others.
Table of Contents
Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Assumptions & Limitations
2.1.1 Assumptions
2.1.2 Limitations
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Share Analysis
3.4 Trade Analysis
3.5 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing demand for diagnosis of chronic disease
4.2.2 Rising prevalence of diabetes leading to high demand of lancets
4.2.3 Favorable Medical Device Regulation
4.2.4 Increasing Geriatric Population
4.3 Restraint
4.3.1 Risk Associated With Capillary Blood Assortment Techniques and Blood Contaminations
4.4 Opportunity
4.4.1 Technological advancement
4.5 Megatrend
4.6 Macroeconomic Indicators
5 Market Impact Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Supply chain analysis
5.2.1 R&D
5.2.2 Parts Manufacturing
5.2.3 Distribution
5.2.4 Marketing & Sales
5.2.5 Post-Sales Monitoring
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunities
6 Global Capillary Blood Collection Devices Market by Material
6.1 Introduction
6.1.1 Plastic
6.1.2 Glass
6.1.3 Stainless Steel
7 Global Capillary Blood Collection Devices Market by Type of Devices
7.1 Introduction
7.1.1 Blood Collecting Tubes and Collector
7.1.2 Lancets
7.1.3 Warming Devices
8 Global Capillary Blood Collection Devices Market by End-User
8.1 Introduction
8.1.1 Hospitals & Clinics
8.1.2 Diagnostic Centres and Pathology Laboratories
8.1.3 Home Diagnostics
9 Global Capillary Blood Collection Devices Market by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 U.K.
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of Middle East & Africa
10 Company Landscape
10.1 Company Market Share Analysis
10.1.1 Introduction
10.2 Competitive Strategies
10.2.1 Introduction
11 Company Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Products
11.1.4 Strategy
11.1.5 Key Developments
11.2 Danaher Corporation
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Products
11.2.4 Strategy
11.2.5 Key Developments
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Products
11.3.4 Strategy
11.3.5 Key Developments
11.4 Novo Nordisk A S
11.4.1 Company Overview
11.4.2 Financials
11.4.3 Products
11.4.4 Strategy
11.4.5 Key Developments
11.5 Becton Dickinson
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Products
11.5.4 Strategy
11.5.5 Key Developments
11.6 Medtronic PLC
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Products
11.6.4 Strategy
11.6.5 Key Developments
11.7 B. Braun Melsungen AG
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Products
11.7.4 Strategy
11.7.5 Key Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Products
11.8.4 Strategy
11.8.5 Key Developments
11.9 Terumo Corporation
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Products
11.9.4 Strategy
11.9.5 Key Developments
11.1 Ypsomed Holding AG
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Products
11.10.4 Strategy
11.10.5 Key Developments
11.11 HTL-STREFA S.A.
11.11.1 Company Overview
11.11.2 Financials
11.11.3 Products
11.11.4 Strategy
11.11.5 Key Developments
11.12 Sarstedt AG & Co
11.12.1 Company Overview
11.12.2 Financials
11.12.3 Products
11.12.4 Strategy
11.12.5 Key Developments
11.13 Owen Mumford Ltd.
11.13.1 Company Overview
11.13.2 Financials
11.13.3 Products
11.13.4 Strategy
11.13.5 Key Developments
11.14 Greiner Bio One
11.14.1 Company Overview
11.14.2 Financials
11.14.3 Products
11.14.4 Strategy
11.14.5 Key Developments
11.15 Improve Medical
11.15.1 Company Overview
11.15.2 Financials
11.15.3 Products
11.15.4 Strategy
11.15.5 Key Developments
12 Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.2 Key Companies to Watch
13 Appendix
13.1 Discussion Blue Print
13.1 Recent Developments, 2014-2017
